Remove 2004 Remove Controlled Substances Remove FDA
article thumbnail

Senators to DEA: Consider Treaty Obligations In Marijuana Rescheduling

The FDA Law Blog

Houck — Administrator Anne Milgram has been on the receiving end of high-level support for and against rescheduling marijuana since the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended the Drug Enforcement Administration (“DEA”) reschedule from schedule I to schedule III last August. By Larry K.

article thumbnail

DEA Regs Bulk Up with 2014 Anabolic Steroid Control Law Additions

The FDA Law Blog

Houck — Anabolic steroids that include testosterone, methyltestosterone, nandrolone decanoate and oxandrolone are schedule III controlled substances with currently accepted medical uses in the U.S. DASCA amended the CSA definition of “anabolic steroid” by adding 22 new substances to the prior list. By Larry K.

article thumbnail

Methocarbamol vs. tizanidine: Differences, similarities, and side effects

The Checkup by Singlecare

Methocarbamol , the generic form of Robaxin , is a centrally acting muscle relaxant available as an oral tablet approved by the Food and Drug Administration (FDA) for short-term relief of acute muscle pain caused by sprains, strains, and other musculoskeletal conditions in people ages 16 and older. What is methocarbamol?